Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin αvβ3 antagonist
We have recently reported on the development of fb-PMT (NP751), a conjugate of the thyroid hormone metabolite tetraiodothyroacetic acid (tetrac) and monodisperse polyethylene glycol 36. It exhibited high affinity for thyrointegrin αvβ3 receptor and potent anti-angiogenic and anticancer activity in v...
Main Authors: | Kazutoshi Fujioka, Bruce A. Hay, Kavitha Godugu, Shaker A. Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.902141/full |
Similar Items
-
Anti-Cancer Activities of Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma
by: Kavitha Godugu, et al.
Published: (2021-06-01) -
Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management
by: Thangirala Sudha, et al.
Published: (2021-08-01) -
Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells
by: Paul J. Davis, et al.
Published: (2020-07-01) -
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer
by: Thangirala Sudha, et al.
Published: (2022-03-01) -
Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. <i>Cancers</i> 2021, <i>13</i>, 2780
by: Kavitha Godugu, et al.
Published: (2022-10-01)